|
[1]
|
ADI (2023) Dementia Facts & Figures. https://www.alzint.org/about/dementia-facts-figures
|
|
[2]
|
Weller, J. and Budson, A. (2018) Current Understanding of Alzheimer’s Disease Diagnosis and Treatment. F1000Research, 7, 1161. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chiti, F. and Dobson, C.M. (2017) Protein Mis-folding, Amyloid Formation, and Human Disease: A Summary of Progress over the Last Decade. Annual Review of Biochemistry, 86, 27-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Bishehsari, F., Magno, E., Swanson, G., et al. (2017) Alcohol and Gut-Derived Inflammation. Alcohol Research, 38, 163-171.
|
|
[5]
|
Crews, F.T. (2008) Alco-hol-Related Neurodegeneration and Recovery: Mechanisms from Animal Models. Alcohol Research & Health, 31, 377-388.
|
|
[6]
|
León, B.E., Kang, S., Franca-Solomon, G., et al. (2021) Alcohol-Induced Neuroinflammatory Re-sponse and Mitochondrial Dysfunction on Aging and Alzheimer’s Disease. Frontiers in Behavioral Neuroscience, 15, Article ID: 778456. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Peng, B., Yang, Q., et al. (2020) Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 21, 2316. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Crews, L. and Masliah, E. (2010) Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease. Human Molecular Genetics, 19, R12-R20. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Huang, Y.R. and Liu, R.T. (2020) The Toxicity and Polymorphism of beta-Amyloid Oligomers. International Journal of Molecular Sciences, 21, 4477. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Selkoe, D.J. and Hardy, J. (2016) The Amyloid Hypothesis of Alzheimer’s Disease at 25 Years. EMBO Molecular Medicine, 8, 595-608. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gulisano, W., Maugeri, D., Baltrons, M.A., et al. (2018) Role of Amyloid-beta and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade. Journal of Alzheimer’s Disease, 64, S611-S631. [Google Scholar] [CrossRef]
|
|
[12]
|
Morris, G.P., Clark, I.A. and Vissel, B. (2014) Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer’s Disease. Acta Neuropathologica Communica-tions, 2, 135. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Albayram, O., Herbert, M.K., Kondo, A., et al. (2016) Function and Regulation of Tau Conformations in the Development and Treatment of Traumatic Brain Injury and Neurodegeneration. Cell & Bioscience, 6, 59. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mandelkow, E.M. and Mandelkow, E. (2012) Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration. Cold Spring Harbor Perspectives in Medicine, 2, a6247. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Mashal, Y., Abdelhady, H. and Iyer, A.K. (2022) Comparison of Tau and Amyloid-beta Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease. Biomole-cules, 12, 1001. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Illenberger, S., Zheng-Fischhofer, Q., Preuss, U., et al. (1998) The Endogenous and Cell Cycle-Dependent Phosphorylation of Tau Protein in Living Cells: Implica-tions for Alzheimer’s Disease. Molecular Biology of the Cell, 9, 1495-1512. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
la Joie, R., Visani, A.V., Baker, S.L., et al. (2020) Prospective Longitudinal Atrophy in Alzheimer’s Disease Correlates with the Intensity and Topography of Baseline tau-PET. Science Translational Medicine, 12, 524. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mroczko, B., Groblewska, M. and Litman-Zawadzka, A. (2019) The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD). International Journal of Molecular Sciences, 20, 4661. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ando, K., Oka, M., Ohtake, Y., et al. (2016) Tau Phosphorylation at Alzheimer’s Disease-Related Ser356 Contributes to Tau Stabilization When PAR-1/MARK Activity Is Elevated. Biochemical and Biophysical Research Communications, 478, 929-934. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Huang, F., Wang, M., Liu, R., et al. (2019) CDT2-Controlled Cell Cycle Reentry Regulates the Pathogenesis of Alzheimer’s Disease. Alzheimer’s & Dementia, 15, 217-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Lippai, D., Bala, S., Petrasek, J., et al. (2013) Alcohol-Induced IL-1beta in the Brain Is Mediated by NLRP3/ASC Inflammasome Activation That Amplifies Neuroinflammation. Journal of Leukocyte Biology, 94, 171-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Khan, S., Barve, K.H. and Kumar, M.S. (2020) Recent Advance-ments in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Current Neuropharmacology, 18, 1106-1125. [Google Scholar] [CrossRef]
|
|
[23]
|
Heneka, M.T., Carson, M.J., El, K.J., et al. (2015) Neuroinflammation in Alzheimer’s Disease. The Lancet Neurology, 14, 388-405. [Google Scholar] [CrossRef]
|
|
[24]
|
Cai, Z., Hussain, M.D. and Yan, L.J. (2014) Microglia, Neuroinflammation, and Beta-Amyloid Protein in Alzheimer’s Disease. International Journal of Neuroscience, 124, 307-321. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Doens, D. and Fernandez, P.L. (2014) Micro-glia Receptors and Their Implications in the Response to Amyloid Beta for Alzheimer’s Disease Pathogenesis. Journal of Neuroinflammation, 11, 48. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Gundersen, V., Storm-Mathisen, J. and Bergersen, L.H. (2015) Neuroglial Transmission. Physiological Reviews, 95, 695-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Steardo, L.J., Bronzuoli, M.R., Iacomino, A., et al. (2015) Does Neuroinflammation Turn on the Flame in Alzheimer’s Disease? Focus on Astrocytes. Frontiers in Neurosci-ence, 9, 259. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Gonzalez-Reimers, E., Santolaria-Fernandez, F., Martin-Gonzalez, M.C., et al. (2014) Alcoholism: A Systemic Proinflammatory Condition. World Journal of Gas-troenterology, 20, 14660-14671. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Erickson, E.K., Grantham, E.K., Warden, A.S., et al. (2019) Neuroimmune Signaling in Alcohol Use Disorder. Pharmacology Biochemistry and Behavior, 177, 34-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Liddelow, S.A., Guttenplan, K.A., Clarke, L.E., et al. (2017) Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature, 541, 481-487. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Neupane, S.P. (2016) Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression. Frontiers in Immunology, 7, 655. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Qin, L. and Crews, F.T. (2012) NADPH Oxidase and Reactive Oxygen Species Contribute to Alcohol-Induced Microglial Activation and Neurodegeneration. Journal of Neuroin-flammation, 9, 5. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Zhang, Y., Chen, K., Sloan, S.A., et al. (2014) An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. Journal of Neuroscience, 34, 11929-11947. [Google Scholar] [CrossRef]
|
|
[34]
|
Kawasaki, T. and Kawai, T. (2014) Toll-Like Re-ceptor Signaling Pathways. Frontiers in Immunology, 5, 461. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Ramos, A., Joshi, R.S. and Szabo, G. (2022) Innate Immune Activation: Parallels in Alcohol Use Disorder and Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 15, Article ID: 910298. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Pascual, M., Balino, P., Aragon, C.M., et al. (2015) Cytokines and Chemokines as Biomarkers of Ethanol-Induced Neuroinflammation and Anxiety-Related Behavior: Role of TLR4 and TLR2. Neuropharmacology, 89, 352-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zamanian, J.L., Xu, L., Foo, L.C., et al. (2012) Ge-nomic Analysis of Reactive Astrogliosis. Journal of Neuroscience, 32, 6391-6410. [Google Scholar] [CrossRef]
|
|
[38]
|
Vasile, F., Dossi, E. and Rouach, N. (2017) Human Astrocytes: Structure and Functions in the Healthy Brain. Brain Structure and Function, 222, 2017-2029. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Profaci, C.P., Munji, R.N., Pulido, R.S., et al. (2020) The Blood-Brain Barrier in Health and Disease: Important Unanswered Questions. Journal of Experimental Medicine, 217, e20190062. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Haorah, J., Knipe, B., Gorantla, S., et al. (2007) Alcohol-Induced Blood-Brain Barrier Dysfunction Is Mediated via Inositol 1,4,5-Triphosphate Receptor (IP3R)-Gated Intracellular Calcium Release. Journal of Neurochemistry, 100, 324-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Alikunju, S., Abdul, M.P., Zhang, Y., et al. (2011) The Inflammatory Footprints of Alcohol-Induced Oxidative Damage in Neurovascular Components. Brain, Behavior, and Immunity, 25, S129-S136. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Cryan, J.F., O’riordan, K.J., Cowan, C., et al. (2019) The Mi-crobiota-Gut-Brain Axis. Physiological Reviews, 99, 1877-2013. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Milani, C., Duranti, S., Bottacini, F., et al. (2017) The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Mi-crobiota. Microbiology and Molecular Biology Reviews, 81, e00036-17. [Google Scholar] [CrossRef]
|
|
[44]
|
Khan, M.S., Ikram, M., Park, J.S., et al. (2020) Gut Microbiota, Its Role in Induction of Alzheimer’s Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins. Cells, 9, 853. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Lowe, P.P., Gyongyosi, B., Satishchandran, A., et al. (2018) Re-duced Gut Microbiome Protects from Alcohol-Induced Neuroinflammation and Alters Intestinal and Brain In-flammasome Expression. Journal of Neuroinflammation, 15, 298. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Zhang, T., Han, Y., Wang, J., et al. (2018) Comparative Ep-idemiological Investigation of Alzheimer’s Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD. Frontiers in Aging Neuroscience, 10, 176. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Hillemacher, T., Bachmann, O., Kahl, K.G., et al. (2018) Al-cohol, Microbiome, and Their Effect on Psychiatric Disorders. Progress in Neuro-Psychopharmacology & Bio-logical Psychiatry, 85, 105-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Gushcha, V.K., Lelevich, S.V. and Sheibak, V.M. (2019) Neurotransmitter Disturbances in Some Parts of the Rat Brain and Their Correction under Chronic and Intermittent Alcohol Intoxication. Biomeditsinskaya Khimiya, 65, 21-27. [Google Scholar] [CrossRef]
|
|
[49]
|
Shukla, P.K., Meena, A.S., Dalal, K., et al. (2021) Chronic Stress and Corticosterone Exacerbate Alcohol-Induced Tissue injury in the Gut-Liver-Brain Axis. Scientific Reports, 11, Article No. 826. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Frausto, D.M., Engen, P.A., Naqib, A., et al. (2022) Impact of Alcohol-Induced Intestinal Microbiota Dysbiosis in a Rodent Model of Alzheimer’s Disease. Frontiers in Aging, 3, Article ID: 916336. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Perriard, G., Mathias, A., Enz, L., et al. (2015) Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes. Journal of Neuroinflammation, 12, 119. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Adachi, Y., Moore, L.E., Bradford, B.U., et al. (1995) Anti-biotics Prevent Liver Injury in Rats Following Long-Term Exposure to Ethanol. Gastroenterology, 108, 218-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Crews, F.T., Lawrimore, C.J., Walter, T.J., et al. (2017) The Role of Neuroimmune Signaling in Alcoholism. Neuropharmacology, 122, 56-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Bjarnason, I., Peters, T.J. and Wise, R.J. (1984) The Leaky Gut of Alcoholism: Possible Route of Entry for Toxic Compounds. The Lancet, 1, 179-182. [Google Scholar] [CrossRef]
|
|
[55]
|
Chi, X., Pan, C.Q., Liu, S., et al. (2020) Regulating In-testinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Canadian Journal of Gas-troenterology and Hepatology, 2020, Article ID: 6629196. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Quigley, E. (2017) Microbiota-Brain-Gut Axis and Neurodegen-erative Diseases. Current Neurology and Neuroscience Reports, 17, 94. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Petrasek, J., Iracheta-Vellve, A., Saha, B., et al. (2015) Metabolic Danger Signals, Uric Acid and ATP, Mediate Inflammatory Cross-Talk between Hepatocytes and Immune Cells in Alcoholic Liver Disease. Journal of Leukocyte Biology, 98, 249-256. [Google Scholar] [CrossRef]
|
|
[58]
|
Shield, K.D., Parry, C. and Rehm, J. (2013) Chronic Diseases and Conditions Related to Alcohol Use. Alcohol Research, 35, 155-173.
|
|
[59]
|
Reuter, S., Gupta, S.C., Chaturvedi, M.M., et al. (2010) Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radical Biology and Medicine, 49, 1603-1616. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Cai, Y., Xu, M.J., Koritzinsky, E.H., et al. (2017) Mitochondrial DNA-Enriched Microparticles Promote Acute-on-Chronic Alcoholic Neutrophilia and Hepatotoxicity. JCI Insight, 2, e92634. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Jo, E.K., Kim, J.K., Shin, D.M., et al. (2016) Molecular Mecha-nisms Regulating NLRP3 Inflammasome Activation. Cellular & Molecular Immunology, 13, 148-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Kim, A., Bellar, A., Mcmullen, M.R., et al. (2020) Functionally Di-verse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol-Associated Hepatitis. Hepatology Communications, 4, 1459-1476. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Mottaran, E., Stewart, S.F., Rolla, R., et al. (2002) Lipid Peroxidation Contributes to Immune Reactions Associated with Alcoholic Liver Disease. Free Radical Biology and Medicine, 32, 38-45. [Google Scholar] [CrossRef]
|
|
[64]
|
Wu, D. and Cederbaum, A.I. (2003) Alcohol, Oxidative Stress, and Free Radical Damage. Alcohol Research & Health, 27, 277-284.
|
|
[65]
|
Chen, Z. and Zhong, C. (2014) Oxidative Stress in Alzheimer’s Disease. Neuroscience Bulletin, 30, 271-281. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Crews, F.T. and Nixon, K. (2009) Mechanisms of Neuro-degeneration and Regeneration in Alcoholism. Alcohol and Alcoholism, 44, 115-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Liu, R., Guo, X., Park, Y., et al. (2013) Alcohol Consumption, Types of Alcohol, and Parkinson’s Disease. PLOS ONE, 8, e66452. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Sánchez-Muniz, F.J., Macho-González, A., Garcimartín, A., et al. (2019) The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease. Nutrients, 11, 1558. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Venkataraman, A., Kalk, N., Sewell, G., et al. (2017) Alcohol and Alzheimer’s Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer’s Disease? Alcohol and Alcoholism, 52, 151-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Nutt, D., Hayes, A., Fonville, L., et al. (2021) Alcohol and the Brain. Nutrients, 13, 3938. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Thomson, A.D., Guerrini, I. and Marshall, E.J. (2012) The Evolution and Treatment of Korsakoff’s Syndrome: Out of Sight, out of Mind? Neuropsychology Review, 22, 81-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Oscar-Berman, M. and Marinkovic, K. (2003) Alcoholism and the Brain: An Overview. Alcohol Research & Health, 27, 125-133.
|
|
[73]
|
Guo, R. and Ren, J. (2010) Alcohol and Acetaldehyde in Public Health: From Marvel to Menace. International Journal of Environmental Research and Public Health, 7, 1285-1301. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Nguyen, G.T., Green, E.R. and Mecsas, J. (2017) Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance. Frontiers in Cellular and Infection Microbiology, 7, 373. [Google Scholar] [CrossRef] [PubMed]
|